The Clorox Company

The Clorox Company (CLX) Market Cap

The Clorox Company has a market capitalization of $12.76B.

Financials based on reported quarter end 2025-12-31

Price: $104.58

โ–ฒ 2.20 (2.15%)

Market Cap: 12.76B

NYSE ยท time unavailable

CEO: Linda J. Rendle

Sector: Consumer Defensive

Industry: Household & Personal Products

IPO Date: 1983-03-21

Website: https://www.thecloroxcompany.com

The Clorox Company (CLX) - Company Information

Market Cap: 12.76B ยท Sector: Consumer Defensive

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; natural personal care products under the Burt's Bees brand; and water-filtration products under the Brita brand in the United States. The International segment provides laundry additives; home care products; water-filtration systems; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brands. The Clorox Company sells its products primarily through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force The company was founded in 1913 and is headquartered in Oakland, California.

Analyst Sentiment

47%
Hold

Based on 19 ratings

Analyst 1Y Forecast: $122.61

Average target (based on 5 sources)

Consensus Price Target

Low

$94

Median

$117

High

$152

Average

$119

Potential Upside: 13.6%

Price & Moving Averages

Loading chart...

๐Ÿ“˜ Full Research Report

โ„น๏ธ

AI-Generated Research: This report is for informational purposes only.

๐Ÿ“˜ The Clorox Company (CLX) โ€” Investment Overview

๐Ÿงฉ Business Model Overview

The Clorox Company is a diversified consumer packaged goods (CPG) operator, well known for its portfolio of trusted household and professional products. Spanning cleaning, disinfecting, household essentials, lifestyle, and natural personal care categories, Cloroxโ€™s offerings include iconic brands such as Cloroxยฎ disinfecting wipes and bleach, Gladยฎ trash bags, Kingsfordยฎ charcoal, Burtโ€™s Beesยฎ personal care, and Hidden Valleyยฎ dressings. The company serves three primary customer segments: individual consumers, professional/commercial clients, and institutional/healthcare organizations. Its operational footprint is primarily in North America, with select international exposures, and the business maintains both direct customer relationships and strong retail channel partnerships with major grocery, mass-merchandise, dollar, and e-commerce retailers.

๐Ÿ’ฐ Revenue Model & Ecosystem

Cloroxโ€™s revenue framework is driven by a mix of recurring household purchases, brand licensing, and select professional products for institutions. The primary revenue stream comes from the sale of consumable CPG products under well-established brand names, distributed through retail partners and direct-to-consumer channels. The company also generates growth through product line extensions, innovation in adjacent categories, and value-added offerings to commercial and institutional clients. While the business is primarily volume-based, it benefits from a high degree of repeat purchases due to the consumable and essential nature of its products, creating a resilient revenue ecosystem. Additionally, selective brand collaborations, partnerships, and sustainability-driven initiatives help Clorox deepen customer loyalty while expanding its platform reach.

๐Ÿง  Competitive Advantages

  • Brand strength: Clorox commands high consumer trust and household recognition through decades of consistent product quality and prominent marketing, underscoring its productsโ€™ reliability and safety.
  • Switching costs: Many Clorox products, especially within disinfecting and cleaning, are habitual purchases with minimal consumer trial for alternatives, resulting in steady customer retention.
  • Ecosystem stickiness: Wide product assortment and cross-brand loyalty (e.g., households buying multiple Clorox brands) help embed Clorox within consumersโ€™ shopping routines and retailer shelves.
  • Scale + supply chain leverage: Significant scale enables Clorox to optimize sourcing, manufacturing, and distribution, enhancing its ability to maintain competitive pricing and invest in marketing or innovation ahead of smaller peers.

๐Ÿš€ Growth Drivers Ahead

Clorox is positioned to benefit from evolving consumer behaviors around health, hygiene, and sustainability. Key growth catalysts include ongoing product innovation (such as eco-friendly formulas and convenient packaging), deeper penetration into health and wellness-oriented segments, international expansion into developing markets, and digital transformation of its marketing and sales channels. Clorox continues to invest in sustainability, aiming to lead with natural and environmentally responsible offerings. The professional and institutional channel, especially within healthcare, education, and workplace hygiene, presents long-run expansion opportunities as organizations prioritize dependable cleaning protocols. Integration of data analytics and e-commerce partnerships further enhance brand reach and operational efficiency.

โš  Risk Factors to Monitor

Clorox faces risks from increased competition, both from established CPG competitors and private label/store brands, which may pressure pricing and shelf space. The consumer shift toward value alternatives or natural/organic products presents ongoing disruption risk in certain categories. Regulatory changes impacting ingredient disclosure, product formulations, or environmental standards could drive additional compliance and innovation costs. Supply chain volatility (including raw material price fluctuations and logistics disruptions) may adversely affect margins. Additionally, changing consumer shopping behaviors, particularly the rise of e-commerce and direct-to-consumer models, require continual adaptation.

๐Ÿ“Š Valuation Perspective

Clorox is typically valued by the market at a premium relative to the broader consumer staples sector, reflecting its strong brands, repeat-purchase business model, and stable cash flow generation. Its defensive profile โ€” characterized by resilience in both stable and turbulent economic conditions โ€” supports above-average investor confidence versus more cyclical peers. However, valuation sensitivity emerges when category growth slows or competition intensifies, thus premium status is maintained only so long as brand strength and operating execution remain robust.

๐Ÿ” Investment Takeaway

The Clorox Company represents a classic defensive investment choice, anchored by leading household brands, a culture of innovation, and a strong position in the increasingly health-conscious global consumer landscape. Bulls argue that Clorox's market leadership, diversification, and operational excellence position the company to capitalize on long-term trends surrounding cleanliness, wellness, and sustainability. Skeptics, however, point to rising competitive pressure, potential margin headwinds, and the challenges associated with shifting consumer preferences and regulatory demands. Ultimately, the investment merits depend on Cloroxโ€™s ability to preserve brand loyalty, accelerate growth initiatives, and navigate the evolving demands of retail and regulatory landscapes.


โš  AI-generated research summary โ€” not financial advice. Validate using official filings & independent analysis.

Clorox delivered Q2 results largely in line with expectations and reaffirmed its full-year outlook, with sequential improvement and early January share gains. Management expects a stronger back half driven by a robust innovation pipeline, retailer support, and improving gross margins as ERP-related costs fade and cost savings step up, aided by a Glad JV termination benefit. Competitive and promotional intensity remains elevated, households saw negative pricing, and price/mix is a headwind, but the company is leaning into disciplined promotions, net revenue management, and a completed ERP foundation. Overall tone is cautiously optimistic for 2H execution and share recovery.

Growth

  • Sequential improvement in Q2 vs. Q1; category growth roughly flat (Q2 down ~0.1 pt; Q1 flat ex-Beauty).
  • Expect category growth of 0โ€“1% in 2H; company performance expected to strengthen in back half.
  • January showed consumption pickup and weekly share gains (partly weather-related).
  • Innovation ramp with shelf resets in late Q3/early Q4 expected to drive share and sales.
  • For FY, volume expected to grow slightly ahead of organic sales as price/mix is a ~1% headwind.

Business Development

  • Planned acquisition of Gojo Industries to expand leadership in health and hygiene.
  • 2H innovation slate: allergy-destroying cleaning platform; Glad trash bags with LeakGuard; multi-year relaunch of cat litter (new packaging/claims); Hidden Valley avocado ranch and price-pack architecture.
  • Retailer support secured; investment at roughly 2x typical launch levels; additional waves of allergy platform in pipeline.

Financials

  • Reaffirmed full-year outlook; Q2 results largely in line with internal expectations.
  • Q2 shipments benefited by ~1 pt prebuild ahead of final ERP manufacturing phase; expected to reverse in Q3 with no full-year impact.
  • Gross margin expected to expand in 2H vs 1H; Q3 ~flat, Q4 solid expansion.
  • 2H margin drivers: higher cost-savings run-rate; ERP-related stabilization costs tapering and largely gone by Q4; ~50 bps 2H benefit from Glad JV termination step-up.
  • Price/mix expected to be ~1% headwind for FY; Q2 pricing flattish for company, negative in Household.

Capital & Funding

  • Pending Gojo Industries acquisition (terms/financing not disclosed on call).
  • Glad JV termination benefit flows into 2H margins (~50 bps).

Operations & Strategy

  • ERP implementation completed across manufacturing in January after phased rollouts (July, October, January).
  • Continuing digital transformation and execution enhancements to leverage modernized ERP.
  • Net revenue management and disciplined, targeted promotions to address value-seeking behaviors.
  • Multi-year plan to regain share in Litter; addressing trash category mix shift toward larger sizes.

Market & Outlook

  • Promotional intensity back to pre-COVID norms; pockets of heightened competition in Litter, Glad, and some Home Care.
  • Consumers focused on value; shifting to value channels; increased trips and stock-up; trading to both larger and smaller sizes.
  • Expect category growth of 0โ€“1% in 2H; stronger share performance anticipated as innovations hit shelves.
  • Kingsford minimal impact in Q2 due to seasonality.

Risks Or Headwinds

  • Elevated promotions and competitive pressure in trash bags and cat litter.
  • Price/mix headwind from consumer value-seeking and channel mix shifts.
  • Q3 headwind from reversal of Q2 shipment prebuild.
  • Residual ERP stabilization costs in Q3 and execution risk around broad innovation rollout and shelf resets.
  • Market share still down in Q2 despite sequential improvement.

Sentiment: MIXED

Note: This summary was synthesized by AI from the CLX Q2 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Fundamentals Overview

Loading fundamentals overview...

๐Ÿ“Š AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"Clorox (CLX) reported quarterly revenue of $1.67 billion and net income of $157 million, resulting in an EPS of $1.29. With a net margin of 9.4% and a free cash flow of $269 million, the company exhibits solid profitability and cash flow generation. Year-over-year growth highlights include revenue stability amidst challenging market conditions. Revenue growth appears moderate, underpinned by consistent product demand. The company's net income results in an acceptable net margin of 9.4%, reflecting effective cost management. Free cash flow remains healthy at $269 million, supporting dividend sustainability and share buybacks. Clorox's balance sheet shows total equity at $35 million against substantial liabilities of $5.58 billion, resulting in high leverage with net debt at $2.99 billion. Shareholder returns are emphasized through $151 million in dividends and $129 million in stock repurchases. Current analyst sentiment appears mixed, with a consensus price target of $117.71, against a market query price range $94โ€“$152. Despite solid cash flows, high leverage raises financial resilience concerns. Overall, Clorox maintains strong cash flow and shareholder returns but faces challenges in financial leverage management."

Revenue Growth

Neutral

Growth is moderate; revenue stability maintained through consistent demand.

Profitability

Good

High net margin of 9.4% reflects effective cost management and efficiency.

Cash Flow Quality

Good

Strong free cash flow of $269 million supports dividends and buybacks.

Leverage & Balance Sheet

Fair

High leverage indicated by net debt of $2.99 billion versus minimal equity.

Shareholder Returns

Good

Substantial dividends ($151 million) and buybacks ($129 million) enhance returns.

Analyst Sentiment & Valuation

Neutral

Mixed analyst sentiment; consensus target suggests potential price movement.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Loading financial data and tables...
๐Ÿ“

SEC Filings (CLX)

ยฉ 2026 Stock Market Info โ€” The Clorox Company (CLX) Financial Profile